Theravance Biopharma, Inc. Announces Top-line Results from Phase 2b Dose-Finding Induction Study of Izencitinib in Patients with Ulcerative Colitis
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| (NASDAQ: TBPH) | Delayed: 17.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.03 | 52 Week High | $38.92 | |||
| Open | $17.03 | 52 Week Low | $12.87 | |||
| Day High | $17.03 | P/E | N/A | |||
| Day Low | $17.03 | EPS | $0.00 | |||
| Volume | 75,260 | |||||
